
Glioblastoma Awareness Day will be observed Wednesday, July 19, which makes this a good time to learn about one of the most complex, deadly and treatment-resistant cancers.
More than 14,490 people in the U.S. will be diagnosed with glioblastoma in 2023, according to the National Brain Tumor Society, and 10,000 people in the U.S. will die of the disease. The five-year survival rate is 6.9%, and the median length of survival is eight months.
Glioblastoma, also known as glioblastoma multiforme, is a type of glioma, which are tumors that occur in the brain and spinal cord. Glioblastoma is an aggressive cancer that forms from cells called astrocytes that support nerve cells. Glioblastoma can happen at any age, but it tends to occur more often in older adults and more often in men than women.
Glioma symptoms depend on the location of the glioma. Symptoms also may depend on the type of glioma, its size and how quickly it's growing.
Common signs and symptoms of glioblastoma include:
Treatment may slow progression of the cancer, and reduce signs and symptoms. But glioblastoma can be difficult to treat, and a cure often is not possible. When it comes to developing a care plan, it's important to weigh the benefits of treatment against side effects that might reduce quality of life.
Glioblastoma treatment options include:
Connect with others talking about glioblastoma in the Brain Tumor Support Group on Mayo Clinic Connect, an online patient community moderated by Mayo Clinic.
National Influenza Vaccination Week will be observed Dec. 4–8, which makes this a good time to learn more about the flu and why it's especially important ...
When David Elder’s back started to hurt in the fall of 2022, he thought his recurrent spasms had returned. But when medication didn’t help like ...
When Joanina Gicobi began her Ph.D. degree five years ago at Mayo Clinic Graduate School of Biomedical Sciences, she was interested in thinking creatively about ways ...